HOWARD WEINER to Natalizumab
This is a "connection" page, showing publications HOWARD WEINER has written about Natalizumab.
Connection Strength
0.170
-
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. Int J Neurosci. 2017 May; 127(5):396-403.
Score: 0.124
-
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. Mult Scler. 2014 Sep; 20(10):1381-90.
Score: 0.027
-
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 2009 Jun 02; 72(22):1922-30.
Score: 0.019